Schedule 13G Filing for Palisade Bio, Inc.

Squadron Master Fund LP, Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank have filed a Schedule 13G with the SEC regarding their ownership in Palisade Bio, Inc. The filing indicates that Squadron Master Fund LP owns 7.6% of the common stock, while Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank each own 8.5%. The shares are held through private funds managed by Squadron Capital Management, LLC, which is an investment adviser registered with the SEC. The filing also includes a certification that the securities were not acquired for the purpose of influencing the control of the issuer.